ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,372Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 807

$399K Total Retail Price of All Prescriptions

Rank: 216 out of 807

418 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 418 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 418 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 8,619 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
ATENOLOL 514 475 1 7
WARFARIN SODIUM 412 383 2 10
PRAVASTATIN SODIUM 397 367 3 21
FUROSEMIDE 396 385 4 6
LISINOPRIL 392 354 5 2
OMEPRAZOLE 354 324 6 4
HYDROCHLOROTHIAZIDE 319 290 7 9
SIMVASTATIN 314 289 8 1
POTASSIUM CHLORIDE 236 218 9 18
LEVOTHYROXINE SODIUM 206 189 10 3
LOSARTAN POTASSIUM 198 195 11 14
METFORMIN HCL 164 155 12 12
MIRTAZAPINE 139 139 13 38
TAMSULOSIN HCL 134 119 14 27
ZETIA 126 105 15 59
HYDROCODONE-ACETAMINOPHEN 123 108 S3 16 15
METOPROLOL TARTRATE 121 116 17 8
ATORVASTATIN CALCIUM 112 101 18 11
ALENDRONATE SODIUM 111 95 19 20
DONEPEZIL HCL 111 111 19 31
PREDNISONE 107 100 21 24
NAMENDA 100 84 22 54
AMLODIPINE BESYLATE 94 92 23 5
TRAMADOL HCL 84 72 24 19
PROPRANOLOL HCL 81 81 25 101
TAMIFLU 80 79 26 170
GLYBURIDE 78 78 R 27 80
SERTRALINE HCL 78 71 27 22
ALLOPURINOL 75 75 29 26
DIGOXIN 71 71 30 41
NIFEDIPINE ER 68 68 31 163
CLOPIDOGREL 63 57 32 47
TERAZOSIN HCL 62 62 33 78
PAROXETINE HCL 61 61 34 49
TRAZODONE HCL 60 60 35 25
ISOSORBIDE MONONITRATE ER 60 48 35 36
GABAPENTIN 59 54 37 16
PANTOPRAZOLE SODIUM 57 57 38 44
CITALOPRAM HBR 54 47 39 17
ADVAIR DISKUS 51 49 40 33
ACETAMINOPHEN-CODEINE 51 51 S3 40 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.